Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Treat 1% of 1.6M U.S. Diabetes 1 Patients

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Sep 08, 2022 3:07pm

293 Views

Post# 34950210

Treat 1% of 1.6M U.S. Diabetes 1 Patients

x average price of $300,000 - 400,000 per patient generates over $5Billion in Growth annually.
Phil said annually, however he also said pouch last for 2 yr period. Altho #1Patient is still
fine after 2 1/2 years. Thus each year treat 1% of the 1.6M . The Health Insce companies have taken into consideratoin with this high price tag,they will not have to spend to treat the cost of side effects once the patient is cured of diabetes.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"